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Schistosomiasis, caused by dioecious ﬂatworms in the genus Schistosoma, is torturing
people frommany developing countries nowadays and frequently leads to severemorbidity
and mortality of the patients. Praziquantel based chemotherapy and morbidity control for
this disease adopted currently necessitate viable and efﬁcient diagnostic technologies.
Fortunately, those “-omics” researches, which rely on high-throughput experimental tech-
nologies to produce massive amounts of informative data, have substantially contributed
to the exploitation and innovation of diagnostic tools of schistosomiasis. In its ﬁrst section,
this review provides a concise conclusion on the progresses pertaining to schistosomal
“-omics” researches to date, followed by a comprehensive section on the diagnostic
methods of schistosomiasis, especially those innovative ones based on the detection of
antibodies, antigens, nucleic acids, and metabolites with a focus on those achievements
inspired by “-omics” researches. Finally, suggestions about the design of future diagnostic
tools of schistosomiasis are proposed, in order to better harness those data produced by
“-omics” studies.
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Schistosomiasis or “Bilharziasis” refers to the parasitic diseases
caused by dioecious ﬂatworms in the genus Schistosoma. The main
pathogenic species of human schistosomiasis comprise Schisto-
soma mansoni, S. japonicum, and S. haematobium. Free living
larvae of these pathogens released by variant kinds of snails in the
freshwater, i.e., the cercariae can penetrate the skin of their deﬁnite
hosts and subsequently bring about either egg-induced chronic
responses, known as intestinal schistosomiasis (S. mansoni and
S. japonicum) and urinary schistosomiasis (S. haematobium; Hu
et al., 2004), or, less frequently, some acute reactions like toxemia
or cytokine-induced shock (Wynn et al., 2004). These highly debil-
itating symptoms account for the severe morbidity and mortality
incurred by schistosomiasis and render it a key poverty contribu-
tor for some developing countries in the tropical and subtropical
regions. Moreover, schistosomiasis has also become an emerging
threat in non-endemic areas due to the mounting numbers of
immigrants and tourists (Patz et al., 2000; Enk et al., 2010). Cur-
rently, praziquantel (PZQ) based chemotherapy and morbidity
control have become the predominantly adopted strategy for the
treatment and control of schistosomiasis worldwide (Qing-Wu
et al., 2002; Zhou et al., 2011b). Consequently, monitoring dis-
ease transmission, seeking patients for treatment in endemic areas
and the evaluation of remedies entail viable and efﬁcient diag-
nostic technologies, in order to optimize the extant control and
prevention project for schistosomiasis (Balog et al., 2010).
STATUS QUO OF THE CURRENT SCHISTOSOMAL “-OMICS”
RESEARCHES
“-omics” is a sufﬁx labeling a series of biological subjects that
adopt high-throughput experimental technologies to produce a
large body of holistic and informative data. Since the launch-
ing of the Schistosoma Genome Project propelled by the WHO in
1994 (Oliveira et al., 2008), colossal progresses have been made in
various Schistosoma -omics arenas including genomics, transcrip-
tomics, proteomics, metabonomics (Ju et al., 2010), to name but
a few. Besides an augmented understanding of schistosome biol-
ogy and pathogenesis, those knowledge acquired by Schistosoma
-omics researches also substantially contribute to the exploita-
tion and innovation of drugs, vaccines as well as diagnostic tools
for schistosomiasis. This review aims to display the representative
achievements of those schistosomal -omics researches and con-
clude the diagnostic inventions derived from or at least inspired
by those -omics studies.
TRANSCRIPOMICS
Schistosoma transcriptomics research commenced from the estab-
lishment of complementary DNA (cDNA) libraries which gen-
erated expressed sequence tags (ESTs) from nearly all stages
of S. mansoni and S. japonicum (Fan et al., 1998; Fung et al.,
2002; Hu et al., 2003; Peng et al., 2003; Shabaan et al., 2003;
Verjovski-Almeida et al., 2003; Merrick et al., 2009). After the
obtainment of numerous ESTs data, microarray and serial anal-
ysis of gene expression (SAGE) technology have been used to
proﬁle the transcripts of schistosomes in different stages and/or
under distinct conditions. In particular, Geoffrey Gobert classi-
ﬁed these transcriptomics applications into four main categories
(Gobert, 2010), i.e., (a) characterizing individual cell/tissue
types, (Jones et al., 2007; Gobert et al., 2009a), (b) proﬁling
the intact organism and lifecycle (Hoffmann et al., 2002; Fitz-
patrick et al., 2004, 2005, 2009; Hoffmann and Fitzpatrick, 2004;
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Chai et al., 2006; Dillon et al., 2006, 2008; Gobert et al., 2006,
2009b; Moertel et al., 2006; Vermeire et al., 2006; Jolly et al., 2007;
Ojopi et al., 2007; Williams et al., 2007; Hu et al., 2009; Taft
et al., 2009), (c) parasite–host interactions and effect of ther-
apies on parasite (Hoffmann et al., 2001; Alger and Williams,
2002; Sandler et al., 2003; Aragon et al., 2008, 2009; Gobert and
Jones, 2008; de Moraes Mourão et al., 2009; You et al., 2009;
Burke et al., 2010; Gobert et al., 2010), and (d) gene expres-
sion differences between geographical isolates or species (Le
et al., 2002; Fitzpatrick et al., 2004; Moertel et al., 2006). Not
until 2012 was the transcriptome of the adult and egg stages
of S. haematobium proﬁled along with its genome (Young et al.,
2012).
MicroRNA (miRNA) GENOMICS
UnlikemessengerRNAs (mRNAs), small non-codingRNAs (sncR-
NAs) represent a group of untranslatable transcripts which are
approximately 18–30 nt in length and serve as critical regulators
to silence or activate speciﬁc target genes in a variety of organisms
(Bartel, 2004; Molnar et al., 2010). Endogenous-small interfering
(Endo-siRNAs), miRNAs, and Piwi-interacting RNA (piRNAs)
are three main components of sncRNAs (Kim, 2005). Using
protocols similar to the conventional transcriptomic researches,
which can be outlined as RNA isolation, library construction, and
sequencing (Cheng and Jin, 2012), vast numbers of schistoso-
mal miRNAs and endo-siRNAs have been successfully detected in
S. mansoni (Copeland et al., 2009; de Souza Gomes et al., 2011;
Simões et al., 2011) and S. japonicum (Xue et al., 2008; Copeland
et al., 2009; Hao et al., 2010; Wang et al., 2010b; Cai et al., 2011).
What’s more, recently Cai et al. (2012) adopted a totally novel
method, i.e., the immunoprecipitation of SjAgo2, a key fac-
tor in sncRNAs biogenesis with monoclonal antibodies (mAbs)
to identify and characterize the associated small RNAs. Further
classiﬁcation steps showed that endo-siRNAs derived from trans-
posable elements (TEs) were prominent among those conjugated
sncRNAs.
PROTEOMICS
Since the correlation between transcriptional level and transla-
tional level of one expressed gene is not necessarily straightfor-
ward, proteomic analyses are also of great importance aiming at
the characterization and comparison of functions, abundance,
and subcellular localization (Ju et al., 2010) of numerous gene
products derived from single or multiple samples. In a typical pro-
teomics research, schistosomal specimen would be separated by
one dimensional-(1D-) or 2D-polyacrylamide gel electrophoresis
(PAGE) in the beginning. Subsequently, the isolated bands or spots
would be subjected to digestion and either Matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometer (MALDI-
TOF-MS) or liquid chromatography-tandem mass spectrometry
(LC-MS/MS) according to the separation method. Finally, protein
identities within the sample would be acquired through compar-
ing the mass spectrometry (MS) results to the theoretical masses
stocked in a particular database (van Hellemond et al., 2007).
Based on the purpose of proteomics researches, schistosomal sam-
ples ought to be prepared in different ways. So far, schistosomal
proteomics has been applied to the investigation and comparison
of protein compositions in various developmental stages (Curwen
et al., 2004; Liu et al., 2006) or between different genders (Cheng
et al., 2005; Liu et al., 2006) and the worm proteins might be pre-
fractioned accordingly, e.g., soluble membrane protein (Curwen
et al., 2004; Cheng et al., 2005), tegumental fractions (Van Balkom
et al., 2005; Braschi et al., 2006; Braschi andWilson, 2006; Liu et al.,
2006; Mulvenna et al., 2010; Castro-Borges et al., 2011), secreted
antigens (Knudsen et al., 2005; Curwen et al., 2006; Liu et al., 2009),
gut contents (Delcroix et al., 2007), etc.
IMMUNOMICS
Immunomics is a study that combines proteomics with serology
and aims at ascertaining the interaction between host immune
system and exotic antigens after pathogen invasion. Early schisto-
somal immunomics work utilized combined 2D Western blotting
and MS to identify and compare proteins recognized by serum
samples from S. haematobium exposed patients before and after
PZQ treatment (Mutapi et al., 2005) or with different ages and
infection intensities (Mutapi et al., 2008). Afterwards, an immu-
nomics protein microarray technology was also applied in an
attempt to seek prospective vaccine targets (Driguez et al., 2010).
This advanced technology consists of several steps including
genes selection, cell-free expression, chip printing, and serological
probing.
GLYCOMICS
In view of the critical role glycans played in the induction
of innate immune responses during schistosome–host inter-
play, glycomics, the proﬁling of the schistosomal protein- and
lipid-conjugated glycan or glycan elements was addressed even
before the screening of schistosomal transcriptomics and pro-
teomics (Hokke et al., 2007). So far, the patterns of glycoconju-
gates expressed by multiple life stages of S. mansoni have been
precisely elucidated by either anticarbohydrate mAbs identiﬁ-
cation or MS-based method (Khoo et al., 1995, 1997a,b, 2001;
van Remoortere et al., 2000, 2003; Wuhrer et al., 2000, 2002,
2006a,b; Huang et al., 2001; Nyame et al., 2003; Robijn et al., 2005,
2007a,b).
GENOMICS
Under the continual efforts from two consortia of researchers,
the genome of S. mansoni and S. japonicum were deciphered
and published simultaneously in 2009 (Berriman et al., 2009; The
Schistosoma japonicum Genome Sequencing and Functional Anal-
ysis Consortium, 2009). Three years later, the genome information
of S. haematobium, the pathogen causing urogenital schistoso-
miasis also became accessible (Young et al., 2012). Overall, the
genome of the preceding three main causative human schistoso-
miasis pathogens are organized into eight chromosomes, including
seven pairs of autosomes and a pair of ZW type sex chro-
mosomes. The genome of S. mansoni (363 Mb), S. japonicum
(397 Mb), and S. haematobium (385 Mb) encompass 13,184,
13,469, and 13,073 protein-coding genes, respectively, and a
considerable proportion of them were mapped into gene ontol-
ogy (GO) categories. Apart form those protein coding genes,
more than 40% of these three genomes are taken up by repet-
itive elements, which contains retrotransposons, satellites, DNA
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transposons and other kinds of unknown repeats. As a whole, the
relationship between S. mansoni and S. haematobium are more
intimate than either of them with S. japonicum (Young et al.,
2012).
METABONOMICS
Schistosomes-related metabonomics keeps tabs on the overall
changes of metabolites within tissues and bioﬂuids of the hosts
before and after blood ﬂuke infection. Metabonomics-based schis-
tosomiasis biomarker discoveries were pioneered in 2004 by
Wang et al. (2004), who used 1H nuclear magnetic resonance
(NMR) spectroscopy and multivariate pattern recognition to ana-
lyze the metabolic signature of urine samples from S. mansoni
infectedmice. Subsequently, using various spectroscopicmethods,
e.g., NMR spectroscopy, MS, and capillary electrophoresis (CE),
coupled with various data-mining technologies (Legido-Quigley,
2010), severalmetabonomics related to schistosome infectionwere
proﬁled, such as urine samples from mice infected with S. man-
soni (Garcia-Perez et al., 2008, 2009, 2010) and hamsters infected
with S. japonicum (Wang et al., 2006), as well as blood and mul-
tiple tissue samples from schistosome-alone infected (Li et al.,
2009) or two pathogens co-infected rodents (Wu et al., 2010). It
was not until early this decade that one metabonomic investiga-
tion started to survey human Schistosoma spp. infection (Balog
et al., 2011). Corresponding works will be reviewed in the next
section.
THE “NEW GENERATION” DIAGNOSTIC METHODS FOR
SCHISTOSOMIASIS AND THEIR PROGRESSES IMPELLED BY
THE “-OMICS” ACHIEVEMENTS
TRADITIONAL, ETIOLOGICAL DIAGNOSTIC METHODS
Etiological diagnosis of schistosomiasis, i.e., the microscopic
detection of schistosome eggs in urine (S. haematobium) or stool
(S. mansoni and S. japonicum) samples is the most straight-
forward and widely adopted diagnostic approach to investigate
the infection of schistosomes (Utzinger et al., 2011). Repre-
sentative methods of etiological diagnosis include Kato–Katz
(KK) thick smear (Katz et al., 1972), miracidium hatching
assay (Jurberg et al., 2008), egg ﬂoating technique (FLOTAC;
Cringoli, 2006), nuclepore urine ﬁltration (Mott et al., 1982),
etc. Those etiological methods are deemed as the “gold
standard” for the detection of cases particularly in high
endemicity settings and in the early stage of a control pro-
gram. However, after mass drug administration or in low
transmission settings, these traditional methods show limited
sensitivity and accuracy (Zhao et al., 2012). In addition, mul-
tiple stool examinations or combined techniques, although
reduced the false-negative rate to some extent, are quite time-
consuming and labor-intensive, which hindered their applica-
tion in large-scale epidemiological surveys (Zhou et al., 2011b).
Thus, they have been gradually replaced by immunologi-
cal techniques based on antigen or antibody detection, as
well as PCR-based molecular tools, metabolic proﬁling, i.e.,
those so-called “new generation” diagnostic methods. Mean-
while, those novel diagnostic methods have beneﬁted con-
tinuously from the previously introduced “-omics” researches
(Table 1).
ANTIBODY-BASED, INDIRECT IMMUNOLOGICAL TECHNIQUES
Indirect immunodiagnostic assays use a range of immunologi-
cal methods, such as circumoval precipitin test (COPT), indi-
rect hemagglutination assay (IHA), dipstick dye immunoassay
(DDIA), and enzyme-linked immonosorbent assay (ELISA; Zhu,
2005), etc. in order to detect schistosome-speciﬁc antibodies.
Immunodiagnosis based on the detection of antibodies is rela-
tively repeatable, sensitive, tractable, and time-saving compared
with traditional etiological methods. Early indirect immunodi-
agnosis mainly relied on the crude extracts of worm compo-
nents, like microsomal extract, gut-associated polysaccharide,
non-fractionated extracts of eggs, etc. (Doenhoff et al., 2004)
as diagnostic antigens. However, the usage of crude antigens
frequently poses a cross-reaction problem because of those com-
ponents within the crude antigens shared with other, irrelevant
pathogens (Jin et al., 2010). Besides, antibody-based serological
assays are not quantitative and usually fail to discriminate between
previous exposure and current infection. Although it is difﬁcult to
eradicate all of these innate drawbacks of these diagnostic tech-
niques, they could be alleviated to some extent by the use of
selected recombinant antigens (Doenhoff et al., 2004). Thanks to
the enormous amount of gene sequence information procured
by the transcriptomics and genomics researches, together with
those screening methods including proteomics, immunomics as
well as some bioinformatics tools, many promising diagnostic
antigens have been identiﬁed and their immunogenicity have
been testiﬁed, vastly enriching the diagnostic antigen pools for
schistosomiasis.
Complementary DNA libraries represent a sort of precious
transcriptomic resources. Under combined efforts of serological
screening and immunological veriﬁcation, schistosomal antigens
with high immunogenicity could be identiﬁed in a cDNA library
and ﬁnally applied to antibody-based immunodiagnosis of schis-
tosomiasis. Zhou et al. (2010) used rabbit sera collected on day
21 post-infection in an antigenic screening of a previously con-
structed cercariae cDNA library of S. japonicum (Fung et al., 2002).
From the identiﬁed positive clones, the authors ﬁnally selected
Sjp40 as an antigen candidate and used time-resolved ﬂuoroim-
munoassay (TRFIA) to proﬁle the levels of anti-Sjp40 IgG in
the sera of rabbits with different days post-infection. The result
showed that compared with the controls at each time interval,
since 21 days post-infection, the titer of circulatory anti-Sjp40 IgG
in the infected groups started to signiﬁcantly increase. Thus, it was
considered that Sjp40 was a potential antigen for early diagnosis
of schistosomiasis.
Likewise, another group of researchers (Zhou et al., 2009) used
human saliva, instead of rabbit sera, to screen a cDNA library of
S. japonicum eggs, which resulted in the detection of Sj13. The
following ELISA assay exhibited 92.50% sensitivity and 92.11%
speciﬁcity of salivary IgG detection with recombinant Sj13. Given
the easy-accessibility and non-invasiveness of the saliva samples,
saliva/Sj13 was asserted as a promising alternative to serologi-
cal test for schistosomiasis. In addition to these two examples,
numerous antigens, sorted from the cDNA library established
in 2003 (Hu et al., 2003), like SjEFCAB (Lu et al., 2012a), SjE16
(Wang et al., 2003), Sj myophilin-like protein (Peng et al., 2008),
P7 antigen (Xu et al., 2011), etc. have been cloned and expressed
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Table 1 | An overview of “-omics” researches’ contribution to the revelation of novel schistosomiasis diagnostic targets.
Diagnostic techniques “-omics” researches Representative diagnostic targets
Antibody-based
immunodiagnosis
Transcriptomics Fung et al. (2002) Sjp40 (Zhou et al., 2010)
Wu et al. (1998) Sj13 (Zhou et al., 2009)
Hu et al. (2003) SjEFCAB (Lu et al., 2012a), SjE16 (Wang et al., 2003), Sj
myophilin-like protein (Peng et al., 2008), P7 antigen (Xu
et al., 2011), 14-3-3 (Zheng et al., 2007), etc.
Genomics Berriman et al. (2009) Sm200, Sm12.8, Sm43.5, Sm127.9, Sm18.9, Sm16.5
(Carvalho et al., 2011)
The Schistosoma japonicum
Genome Sequencing and
Functional Analysis
Consortium (2009)
Sj1TR, Sj4TR, Sj7TR (Angeles et al., 2011)
Immunomics Zhong et al. (2010) SjLAP and SjFBPA (Zhong et al., 2010)
Antigen-based
immunodiagnosis
Immunomics Lu et al. (2012b) protein BUD31 homolog, ribonuclease, SJCHGC06971
protein and SJCHGC04754 protein
PCR-based molecular
method
Genomics The Schistosoma japonicum
Genome Sequencing and
Functional Analysis
Consortium (2009)
SjCHGCS19 (Guo et al., 2012)
Metabolic biomarkers
discovery
Metabonomics Balog et al. (2011) Dimethylamine, Hippurate, PAG, etc. (Balog et al., 2011)
in E. coli prokaryotic expression system even earlier and their
immunogenicity and diagnostic potential were also investigated.
Despite of their considerable sensitivity and speciﬁcity as diag-
nostic antigens, since most of them were published in Chinese
journals, their signiﬁcance thereby waned.
Besides cDNA libraries, schistosomal genomes stand for
another kind of resources to search potential indirect diagnos-
tic antigens for schistosomiasis. Using bioinformatics screening,
another group succeeded in identifying several novel diagnos-
tic antigen candidates from the previously sequenced S. mansoni
genome (Berriman et al., 2009). Overall, four criteria were used in
the in silico analysis strategy, including expression in all parasite life
stage within the deﬁnitive host, extracellular or plasmatic mem-
brane localization, low similarity to human and other helminthic
proteins and presence of predicted B cell epitopes (Carvalho et al.,
2011). As a result, six promising diagnostic antigens (Sm200,
Sm12.8, Sm43.5, Sm127.9, Sm18.9, Sm16.5) were elicited from
13,197 transcripts described for S.mansoni (Berriman et al., 2009).
Ensuing veriﬁcation steps including 1D- and 2D-Western blotting
using schistosomula antigen preparation, adult worm preparation
and sera from infected mice indicated the good immunogenicity
of those predicted antigens.
Furthermore, bioinformatics techniques also served as screen-
ing tools to seek antigen candidates for indirect immunological
diagnosis in the S. japonicum genome (Angeles et al., 2011). A
group of antigens termed tandem repeat (TR) proteins were tar-
geted in this study because of their role in humoral responses
known previously (Kim et al., 2001; Goto et al., 2010). Speciﬁcally
speaking, TR genes were identiﬁed from S. japonicum genome by
a program named Tandem Repeats Finder. A total of 12,657 gene
sequences were analyzed and 134 genes were found to have TR
regions. Four TR genes, i.e., Sj1TR, Sj2TR, Sj4TR, and Sj7TR were
selected for further research from the top 20 hits elicited by in sil-
ico screening based on their biochemical properties, conservation
with other organisms, expression evidence, etc. Their recombinant
proteins in expected size were successfully expressed and puri-
ﬁed and ELISA was performed using sera from healthy people
in endemic or non-endemic countries, post-treated individuals,
stool-conﬁrmed patients and patients of other parasitic diseases.
Sj7TR had the highest sensitivity (85.71%), while both Sj1TR
and Sj7TR had 100% speciﬁcity. More importantly, no cross-
reaction with sera from patients infected by other pathogens was
detected among those TR proteins. In contrast, the crude antigen
of S. japonicum, SEA, had a higher sensitivity of 97.14% com-
pared with the recombinant antigens but its speciﬁcity was poor
(71.76%) and cross-reaction emerged with Paragonimus wester-
mani, Opisthorchis viverrini, and Entamoeba histolytica-positive
samples. In conclusion, Sj7TR was a promising candidate antigen
for diagnosis purpose found by this research.
In another study, immunomics methods were also employed to
uncover prospective diagnosis antigens for schistosomiasis (Zhong
et al., 2010). In the beginning, more than 30 immunodominant
spots were recognized by pooled sera from infected rabbits with
Western blotting, 10 of which were precisely matched to the
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homologous 2D-gel. LC/MS-MS was then adopted to identify
those 10 spots and they were found to correspond to four dis-
tinct proteins. Twoof the four identiﬁed proteins that hadnot been
investigated before, namely, SjLAP,a complex of metallopeptidases
and SjFBPA, a central glycolytic enzyme were successfully cloned
and the recombinant protein products were further applied in
the diagnosis of Schistosomiasis japonica by ELISA, which yielded
sensitivities of 98.1 and 87.8% for acute and chronic schistosomi-
asis with rSjLAP and 100 and 84.7% with rSjFBPA, respectively,
whereas the speciﬁcities were 96.7% for both antigens. Moreover,
both antigen ELISA assays showed more than 80% sensitivity in
diagnosis of chronic schistosomiasis with a low intensity infection
and signiﬁcantly declined antibody titers after the treatment with
PZQ. Thus, rSjLAP and rSjFBPA proved to be useful diagnostic
antigens for S. japonicum infection.
ANTIGEN-BASED DIRECT IMMUNOLOGICAL DIAGNOSIS
Early immunoassays have shown that schistosome-derived anti-
gens, such as adult worm antigen (AWA), soluble egg antigen
(SEA), and circulating antigen (CA; Zhao et al., 2012) could be
released into the host circulatory system/excreta by schistosomes,
which facilitates the researches on the direct immunological diag-
nosis of schistosomiasis. Circulating anodic antigen (CAA) and
circulating cathodic antigen (CCA) are by far the most exten-
sively used antigens for the antigen-based immunodiagnosis of
schistosomiasis and methods for the detection of CAs encom-
pass sandwich ELISA (De Jonge et al., 1988), IHA (Deelder
et al., 1989), time-resolved immunoﬂuorometric assay (TR-IFMA;
De Jonge et al., 1989), magnetic bead immunoassay (Gunder-
sen et al., 1992), reagent strips (Van Etten et al., 1994), and
liquid-phase piezoelectric immunosensor (LP-PEIS; Wen et al.,
2011). Compared with the two foregoing diagnostic methods, the
detection of CA is more suitable for drug efﬁcacy trials owing
to its high speciﬁcity and the ability to discriminate between
previous exposure and current infection. Moreover, CAA and
CCA can be readily detected in urine (Van Dam et al., 2004),
which is easier and less invasive to be collected than blood
required for antibody detection. Nonetheless, low sensitivity
(Van Lieshout et al., 1995, 2000), failing to distinguish different
species (Agnew et al., 1995) are disadvantages associated with this
method.
Research conducted by Lu et al. (2012b) becomes the ﬁrst and
currently the sole immunomics-based study in an attempt to
proﬁle CAs in Schistosoma spp. In this study, AWA was initially
prepared using S. japonicumworms collected from infected rabbits
and then employed to subcutaneously immunize the hyline hens so
as to produce anti-AWA IgY. The IgY antibody contained in the egg
yolkwas puriﬁed bywater-dilution and ammonium sulfate precip-
itation approach and characterizedbyELISAandWesternblotting.
Afterwards, puriﬁed IgYwas immobilized onto aldehyde-activated
beaded agarose resin and served as a capture antibody to immuno-
precipitate and enrich CAs within the sera of patients. At last, the
obtained CAs were separated by 1D electrophoresis and analyzed
by LC-MS/MS, which lead to the identiﬁcation of four proteins,
i.e., protein BUD31 homolog, ribonuclease, SJCHGC06971 pro-
tein, and SJCHGC04754 protein. The following analysis indicated
that those fourCAs belonged to neither CAAnorCCA and had not
been reported from previous proteomics researches. CAs revealed
by corresponding -omics researches, just like these four, ought to
be cloned and expressed in the future and the produced mAbs
could be applied for antigen detection through sandwich ELISA
which stands for a promising way to overcome the shortcomings
of the current direct immunodiagnostic methods.
In addition to this ﬁnished work, one recent review about pro-
teomics at the schistosome–mammalian host interface (Wilson,
2012) also proposed several candidate antigens that can be poten-
tially used for CA detection, including serpin, α2 macroglobulin,
Am200, LMWP, as well as some MEG-2 and MEG-3 proteins
secreted by eggs.
NUCLEIC ACID AMPLIFICATION-BASED MOLECULAR METHODS
Given the existence of schistosomal DNA in the serum and other
tissue samples of the host derived from dead worms, tegument
shedding or inactive eggs (Xu et al., 2013), PCR-based molecu-
lar diagnosis has become a promising alternative to overcome the
innate shortcomings of etiological and immunological diagnosis
for schistosomiasis. Since the publication of the proof-of-concept
study in 2002 (Pontes et al., 2002), PCR-based molecular diagno-
sis has been applied to the detection of schistosomes in multiple
diagnostic ﬁeld works (Pontes et al., 2003; Obeng et al., 2008;
Enk et al., 2012) and several novel technologies, such as real time
PCR (RT-PCR; Lier et al., 2006), PCR-ELISA (Gomes et al., 2010),
and loop-mediated isothermal ampliﬁcation (LAMP; Xu et al.,
2010), etc. have been added to the tool assemblies in addition
to conventional PCR in order to boost the detection sensitivity.
Empirical evidence showed that molecular diagnosis of schisto-
somiasis has both high sensitivity and high speciﬁcity, enables
detection during larval stage or at least before egg spawning and
can use manifold materials, e.g., feces, serum (Pontes et al., 2002),
plasma (Wichmann et al., 2009), and urine (Sandoval et al., 2006)
as templates, all of which make it superior to the conventional
diagnostic approaches. Factors that impact the result of molec-
ular diagnosis are various and the choice of ampliﬁed products
is deﬁnitely among them. However, conﬁned by the inaccessi-
bility to the schistosomal genome sequence, in the pre-genomic
era, researchers could only select targets for PCR reactions within
limited candidates. Representative examples include two differ-
ent 121-bp repetitive elements in S. mansoni (Hamburger et al.,
1991) or S. haematobium (Hamburger et al., 2001), S. japonicum
18s rDNA (Zhou et al., 2011a), highly repetitive retrotransposon
SjR2 (Laha et al., 2002), mitochondrial NADH1 gene (nad1) of S.
mansoni (Jannotti-Passos et al., 1997) and S. japonicum (Lier et al.,
2008), etc.
As early as 2009, 25 novel retrotransposons had been identiﬁed
along with the decoding of the genome of S. japonicum (The Schis-
tosoma japonicum Genome Sequencing and Functional Analysis
Consortium,2009). Two years later, a large scale selection had been
conducted in order to seek suitable target sequences among those
25 retrotransposons to achieve the sensitive and speciﬁc diagnosis
of S. japonica (Guo et al., 2012). To begin with, primer pairs were
designed for the 25 candidates with SjR2, a previously described
molecular diagnostic target (Xia et al., 2009; Xu et al., 2010), serv-
ing as a positive control. A series of diluted genomic DNA of S.
japonicum were used as the templates in a PCR assay to amplify
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the target fragments and judge the sensitivity of those 25 candi-
dates. The result showed that in addition to SjR2, a new non-LTR
retrotransposon named SjCHGCS19, with the PCR product of
303-bp in length, had high sensitivity for detecting S. japonicum
DNA. Coincidentally, bioinformatics research showed that both
SjCHGCS19 and SjR2 have higher genome proportions, repetitive
complete copies and partial copies and more active ESTs com-
pared with other candidates in the S. japonicum genome, which
may also outline the general features of ideal targets for PCR diag-
nosis of schistosomiasis. Besides, further researches showed that
SjCHGCS19 has good speciﬁcity except for a cross-reaction with
S. mansoni and it is also an ideal PCR product for the early diag-
nosis of schistosomiasis as well as the evaluation of chemotherapy.
At last, the clinical utility of SjCHGCS19 was also tested by diag-
nosing 43 human serum samples from patients of S. japonica and
51 serum samples from healthy individuals. As a result, the sen-
sitivity of 97.67% and the speciﬁcity of 96.07% fully validated
the effectiveness of the SjCHGCS19-based molecular diagnosis of
schistosomiasis.
Parasite-derived miRNAs, comparable to genomic DNA, are
also present in multiple bioﬂuids of the host, such as plasma,
serum, urine, and saliva (Cortez et al., 2011), which implies their
potential as biomarkers for the molecular diagnosis of schistoso-
miasis. Besides, in response to the invasion of pathogens, some
characteristic changes of the host’s miRNAs proﬁle might appear
(Delic´ et al., 2011), which can also serve as hints of infection event.
Nowadays, the available sequences of schistosomal miRNAs, in
association with those approaches established for the proﬁling
of miRNAs, e.g., stem-loop RT-PCR, miRNA array, and high-
throughput sequencing (Vaz et al., 2010) have paved theway for the
future miRNA-based molecular diagnosis of schistosomiasis. For
detailed information about the diagnostic and therapeutic value
of parasite miRNA, see review (Manzano-Román and Siles-Lucas,
2012).
METABONOMICS-BASED BIOMARKER DISCOVERY
As mentioned above, early schistosomal metabonomics focused
on the dynamics of biochemical responses associated with S.
japonicum or S. mansoni infection in multiple bioﬂuids of rodent
models. Corresponding progresses made thus far have been
reviewed in several papers (Legido-Quigley, 2010; Wang et al.,
2010a; Utzinger et al., 2011). To sum up, the metabolic ﬁngerprint
of rodents in response to schistosomes infection can be concluded
as: reduced levels of the tricarboxylic acid cycle intermediates,
stimulated glycolysis, disturbed amino acid metabolism, distur-
bances in the gut microbiota as well as a phenomenon unique to
S. japonicum infection, i.e., the inhibition of short-chain fatty
acids. Despite the considerable progresses achieved in rodent
models, clinical diagnosis of schistosomiasis based on metabo-
nomics still lags behind other -omics methods, because after all,
the physiological mechanisms between rodents in the laboratories
and humans are far from similar. However, the newly published
metabonomic work about human schistosomiasis (Balog et al.,
2011) has laid a solid foundation for the clinical application of
metabonomic outcomes in the future. Prospective molecular sig-
natures of human S. mansoni infection found by this study were
primarily related to changes in gut microﬂora, energy metabolism,
and liver function, in line with the earlier ﬁndings in experimental
animals.
FUTURE DIAGNOSTIC TOOLS OF SCHISTOSOMIASIS AND
ADVICE TO BETTER HARNESS -OMICS ACHIEVEMENTS
In our view, future diagnostic tools of schistosomiasis ought to fol-
low three main developmental trends: (1) Field-applicability, test
kit protocols should be robust, easy to follow, and produce results
within a few minutes without the aid of extra instruments. (2)
Non-invasiveness, diagnostic tools should detect speciﬁc biomark-
ers from easy accessible bioﬂuids, e.g., sweat, urea, or saliva. (3)
High-throughput, diagnostic kits in the next generation should
integrate multiple probes and enable parallel identiﬁcation of
different pathogens.
“-Omics” studies result in a treasure trove of molecular data
on genes, proteins, and metabolites. However, identiﬁcation of
effective diagnostic biomarkers from these data pools requires
bioinformatics tools based on certain criteria. Further summa-
rization of the general features shared by those currently available
diagnostic targets will undoubtedly help us optimize the algo-
rithms for biomarker selection and thereby better utilize the
information generated by -omics studies. Besides, some molec-
ular candidates of great diagnostic value are able to be sorted
directly by -omics tools based on either their positive interactions
with certain bioﬂuids of patients or the changes of their presences
or concentrations in response to parasite infection. Schistoso-
mal samples and/or bioﬂuids of patients used in such researches
should be chosen and combined according to the prospective util-
ity of a diagnostic tool. Immunomics and metabonomics studies
using distinct biological samples should be rigorously designed
and carried out in future, in an attempt to seek more diagnostic
biomarkers that satisfy variant requirements, e.g., to distinguish
infection by different Schistosoma species and/or with different
worm burden, to discriminate between current infection and
previous exposure, etc. Among all available body ﬂuids to date,
priority should be given to those that can be sampled without
invasive procedures in order to achieve a rapid and safe diagnosis.
Last but not least, we should also pay attention to the achievements
of those newly established -omics tools, so as to enrich our arsenal
of schistosomiasis diagnosis with innovative biomarkers.
Progress in the control and prevention of parasitic diseases is
expected to be more rapid and efﬁcient thanks to the achieve-
ments of “-omics” researches, beneﬁtting the health of humans
and animals alike.
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